MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+9.44%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.64B
AUM Growth
+$133M
(+8.9%)
Cap. Flow
+$29.2M
Cap. Flow
% of AUM
1.78%
Top 10 Holdings %
Top 10 Hldgs %
20.23%
Holding
2,600
New
414
Increased
910
Reduced
693
Closed
280
Top Buys
| 1 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$18.4M |
| 2 |
Vanguard Total Bond Market
BND
|
+$12.2M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$7.86M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$7.39M |
| 5 |
PNC Financial Services
PNC
|
+$7.06M |
Top Sells
| 1 |
Union Pacific
UNP
|
+$11.4M |
| 2 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$11.3M |
| 3 |
CELG
Celgene Corp
CELG
|
+$10.1M |
| 4 |
McDonald's
MCD
|
+$9.35M |
| 5 |
Norfolk Southern
NSC
|
+$8.26M |
Sector Composition
| 1 | Technology | 19.35% |
| 2 | Healthcare | 14.15% |
| 3 | Financials | 11.98% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Communication Services | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Openlane
KAR
$3.14B
| $3K | ﹤0.01% |
144
+10
| +7% | +$208 |
|
1902
SPDR S&P Bank ETF
KBE
$1.55B
| $3K | ﹤0.01% |
62
-3
| -5% | -$145 |
|
1903
Kezar Life Sciences
KZR
$29.4M
| $3K | ﹤0.01% |
81
+4
| +5% | +$148 |
|
1904
Liberty Global Class C
LBTYK
$4B
| $3K | ﹤0.01% |
135
+75
| +125% | +$1.67K |
|
1905
Lands' End
LE
$432M
| $3K | ﹤0.01% |
175
| – | – |
|
1906
Lattice Semiconductor
LSCC
$9.05B
| $3K | ﹤0.01% |
188
-1,304
| -87% | -$20.8K |
|
1907
Mustang Bio
MBIO
$10.6M
| $3K | ﹤0.01% |
1
-2
| -67% | -$6K |
|
1908
Nathan's Famous
NATH
$431M
| $3K | ﹤0.01% |
42
+22
| +110% | +$1.57K |
|
1909
NextCure
NXTC
$13.6M
| $3K | ﹤0.01% |
+6
| New | +$3K |
|
1910
Omnicell
OMCL
$1.51B
| $3K | ﹤0.01% |
39
+7
| +22% | +$538 |
|
1911
Omeros
OMER
$290M
| $3K | ﹤0.01% |
+205
| New | +$3K |
|
1912
Option Care Health
OPCH
$4.75B
| $3K | ﹤0.01% |
171
| – | – |
|
1913
OraSure Technologies
OSUR
$245M
| $3K | ﹤0.01% |
+425
| New | +$3K |
|
1914
Plexus
PLXS
$3.68B
| $3K | ﹤0.01% |
+57
| New | +$3K |
|
1915
Prothena Corp
PRTA
$449M
| $3K | ﹤0.01% |
163
-7,727
| -98% | -$142K |
|
1916
Qiagen
QGEN
$10.2B
| $3K | ﹤0.01% |
74
+16
| +28% | +$649 |
|
1917
uniQure
QURE
$960M
| $3K | ﹤0.01% |
+43
| New | +$3K |
|
1918
Ferrari
RACE
$85.4B
| $3K | ﹤0.01% |
19
+14
| +280% | +$2.21K |
|
1919
iShares Silver Trust
SLV
$20.1B
| $3K | ﹤0.01% |
+208
| New | +$3K |
|
1920
Sutro Biopharma
STRO
$82.3M
| $3K | ﹤0.01% |
289
| – | – |
|
|
SUP
1921
DELISTED
Superior Industries International
SUP
| $3K | ﹤0.01% |
1,088
-6,198
| -85% | -$17.1K |
|
1922
TETRA Technologies
TTI
$628M
| $3K | ﹤0.01% |
+1,732
| New | +$3K |
|
1923
Uber
UBER
$199B
| $3K | ﹤0.01% |
92
+61
| +197% | +$1.99K |
|
1924
Unilever
UL
$155B
| $3K | ﹤0.01% |
+58
| New | +$3K |
|
1925
VYNE Therapeutics
VYNE
$7.31M
| $3K | ﹤0.01% |
11
-1
| -8% | -$273 |
|